Quench Bio

Biotechnology
Founded in 2018-01-01
Cambridge, Massachusetts, United States
http://quenchbio.com
For Profit

About Quench Bio

Quench Bio is a developer of gasdermin biology drugs designed to treat severe inflammatory diseases.The company leverages insights into gasdermin biology and innate immunity to develop medicines with lead compounds that target and inhibit the pore-forming protein that mediates the release of inflammatory cytokines, alarmins, DNA and NETs, enabling patients to get relief from inflammatory diseases.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: 960
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue: $1M to $10M
  • Total Funding: 50000000 USD
  • Last Funding: 50000000 USD (Series A)
  • Funding Status: Early Stage Venture

Technology Stack

Quench Bio actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology

Headquarters: Cambridge, Massachusetts, United States